Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fumarylacetoacetate hydrolase domain containing 2 pseudogene 1 (FAHD2P1) is a human gene annotated as a pseudogene. It does not code for a functional protein and is not implicated in any known biological processes, molecular functions, or disease associations. FAHD2P1 is related by sequence to the fumarylacetoacetate hydrolase domain-containing protein family, but unlike its protein-coding relatives (such as FAHD1, FAHD2A, and FAHD2B), FAHD2P1 lacks evidence for expression of a functional protein and is not recognized as a therapeutic or pharmacological target[1][4]. Note: If you are seeking information on related, protein-coding FAH domain-containing molecules (such as FAHD1, FAHD2A, or FAHD2B), those are distinct entities with different functional, classification, and disease relevance profiles[2][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fumarylacetoacetate hydrolase domain containing 2 pseudogene 1 (FAHD2P1).